Cogent Biosciences
COGT
#3151
Rank
S$6.08 B
Marketcap
S$34.99
Share price
-2.14%
Change (1 day)
-23.31%
Change (1 year)

Earnings for Cogent Biosciences (COGT)

Earnings in 2026 (TTM): -S$0.48 Billion

According to Cogent Biosciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.43 Billion a decrease over its 2024 earnings that were of -S$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cogent Biosciences from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.48 Billion14.06%
2025 -S$0.43 Billion22.64%
2024 -S$0.35 Billion27.67%
2023 -S$0.27 Billion40.78%
2022 -S$0.2 Billion95.68%
2021 -S$97.4 Million114.09%
2020 -S$45.5 Million9.67%
2019 -S$41.49 Million-10.63%
2018 -S$46.42 Million37.68%
2017 -S$33.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion-57.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.41 Million-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA